Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
- PMID: 30662690
- PMCID: PMC6315311
- DOI: 10.4081/idr.2018.7744
Changes in the incidence and epidemiology of neonatal group B Streptococcal disease over the last two decades in Crete, Greece
Abstract
Group B streptococcus (GBS) remains a leading cause of neonatal disease. However, GBS rates and prevention strategies vary considerably worldwide. Herein, we investigated the burden and epidemiological trends of neonatal GBS infections in our area (Greece) over the last two decades. We conducted a multicenter retrospective study that includes all cases of culture-proven GBS disease in infants <90 days old in the last 22 years. Neonatal GBS incidence was 0.17/1000 live births (95%CI: 0.11-0.21). A significant increase was noted during the second decade (0.23 vs 0.10/1000, P<0.05). Late onset disease (LOD) significantly increased during the second decade (0.08 vs 0.02, P<0.05). Infants in the LOD group had a higher risk of meningitis (RR 1.8, 95%CI: 1.23-2.71). Long-term neurological sequelae were reported in 42.8% of meningitis cases. The mortality rate was 8%. The incidence of neonatal GBS disease in our area is among the lowest reported, but an increase was noted the last decade mainly due a rise in the LOD. The burden of LOD, the mortality and long-term disability are still substantial, thus effective prevention strategies - including maternal vaccination for neonatal GBS - are needed.
Keywords: Group B streptococcus; early onset; incidence; intrapartum prophylaxis; late onset; neonatal infections.
Conflict of interest statement
Conflict of interest: the authors declare no conflict of interest.
Figures



References
-
- Libster R, Edwards KM, Levent F, et al. Long-term outcomes of group B streptococcal meningitis. Pediatrics 2012; 130:e8-15. - PubMed
-
- Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep 2010;59:1-36. - PubMed
-
- Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000;21:473-83. - PubMed
-
- Ecker KL, Donohue PK, Kim KS, et al. The impact of group B Streptococcus prophylaxis on early onset neonatal infections. J Neonatal Perinatal Med 2013;6:37-44. - PubMed
-
- Matsubara K, Hoshina K, Kondo M, et al. Group B streptococcal disease in infants in the first year of life: a nationwide surveillance study in Japan, 2011-2015. Infection 2017;45:449-58. - PubMed
LinkOut - more resources
Full Text Sources